VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 1581144
Sex: F
Age: 69
State: FL

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: headache; developed on left side of their face, on the temple area of their forehead, there's been a numb; eyelid felt really heavy, like weigthed down; extremely shaky (arms, shoulders, hands); This spontaneous case was reported by a consumer and describes the occurrence of NERVOUS SYSTEM DISORDER (neurological issue), TREMOR (extremely shaky (arms, shoulders, hands)), HYPOAESTHESIA (developed on left side of their face, on the temple area of their forehead, there's been a numb), EYELID IRRITATION (eyelid felt really heavy, like weigthed down) and HEADACHE (headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No historical condition were reported.). Concomitant products included PRAVASTATIN, Botox injections and Prolia vaccine. On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jan-2021, the patient experienced TREMOR (extremely shaky (arms, shoulders, hands)). On 24-Jan-2021, the patient experienced NERVOUS SYSTEM DISORDER (neurological issue), HYPOAESTHESIA (developed on left side of their face, on the temple area of their forehead, there's been a numb) and EYELID IRRITATION (eyelid felt really heavy, like weigthed down). On an unknown date, the patient experienced HEADACHE (headache). On 08-Jan-2021, TREMOR (extremely shaky (arms, shoulders, hands)) had resolved. At the time of the report, NERVOUS SYSTEM DISORDER (neurological issue), HYPOAESTHESIA (developed on left side of their face, on the temple area of their forehead, there's been a numb), EYELID IRRITATION (eyelid felt really heavy, like weigthed down) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Treatment medication included,tylenol Reporter did not allow further contact

Other Meds: PRAVASTATIN; Botox injections; Prolia vaccine

Current Illness:

ID: 1581145
Sex: F
Age: 30
State: KY

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore Injection Site; Numbness of the right side of her face; Burning sensation in the chest for 30 seconds; Numbness of the right side of her neck; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness of the right side of her face), SKIN BURNING SENSATION (Burning sensation in the chest for 30 seconds), HYPOAESTHESIA (Numbness of the right side of her neck) and VACCINATION SITE PAIN (Sore Injection Site) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Numbness of the right side of her face), SKIN BURNING SENSATION (Burning sensation in the chest for 30 seconds), HYPOAESTHESIA (Numbness of the right side of her neck) and VACCINATION SITE PAIN (Sore Injection Site). The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1581146
Sex: F
Age:
State: PA

Vax Date: 01/26/2021
Onset Date: 01/27/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain on the left side; Lump; Painful to eat; A spontaneous case was received from the consumer concerning female patient of unknown age who received Moderna's COVID-19 vaccine and experienced pain on the left side, lump and painful to eat. The patient's medical history was not provided. No relevant concomitant medications were reported. On 26-Jan-2021 prior to the onset of the events, the patient received first of the two planned doses of mRNA-1273 for the prophylaxis of COVID-19 infection. On 27-Jan-2021 the patient experienced she had pain on the left side from her neck, mouth, and ear. She felt like there was a lump. It has been very painful to eat. Treatment of the event was not provided. Action taken with the second dose of mRNA-1273 in response to the event was not reported. The outcome of the events, pain on the left side, lump and painful to eat was not resolved.

Other Meds:

Current Illness:

ID: 1581147
Sex: M
Age: 95
State: NY

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: injection site a little swollen; itchiness at injection; redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (injection site a little swollen), INJECTION SITE PRURITUS (itchiness at injection) and INJECTION SITE ERYTHEMA (redness at injection site) in a 95-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for an unknown indication. The patient's past medical history included No adverse event. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 15-Jan-2021, the patient experienced INJECTION SITE SWELLING (injection site a little swollen), INJECTION SITE PRURITUS (itchiness at injection) and INJECTION SITE ERYTHEMA (redness at injection site). outcome was unknown and not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1581148
Sex: F
Age:
State: AL

Vax Date: 01/14/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash at in injection site; Pain (at injection site); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash at in injection site) and VACCINATION SITE PAIN (Pain (at injection site)) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE RASH (Rash at in injection site) and VACCINATION SITE PAIN (Pain (at injection site)). At the time of the report, VACCINATION SITE RASH (Rash at in injection site) and VACCINATION SITE PAIN (Pain (at injection site)) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1581149
Sex: F
Age: 78
State: CA

Vax Date: 01/19/2021
Onset Date: 01/27/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm was sore, swollen, very itchy, hard, and hot to the touch; pain between her shoulder blades on her left side; arm was sore, swollen, very itchy, hard, and hot to the touch; arm was sore; arm was sore, swollen, very itchy, hard, and hot to the touch; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (arm was sore, swollen, very itchy, hard, and hot to the touch), VACCINATION SITE INDURATION (arm was sore, swollen, very itchy, hard, and hot to the touch), VACCINATION SITE PAIN (arm was sore), VACCINATION SITE SWELLING (arm was sore, swollen, very itchy, hard, and hot to the touch) and ARTHRALGIA (pain between her shoulder blades on her left side) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 37020A(?)) for COVID-19 vaccination. No Medical History information was reported. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE PAIN (arm was sore) and VACCINATION SITE SWELLING (arm was sore, swollen, very itchy, hard, and hot to the touch). On 28-Jan-2021, the patient experienced VACCINATION SITE INDURATION (arm was sore, swollen, very itchy, hard, and hot to the touch). On an unknown date, the patient experienced PRURITUS (arm was sore, swollen, very itchy, hard, and hot to the touch) and ARTHRALGIA (pain between her shoulder blades on her left side). At the time of the report, PRURITUS (arm was sore, swollen, very itchy, hard, and hot to the touch), VACCINATION SITE INDURATION (arm was sore, swollen, very itchy, hard, and hot to the touch), VACCINATION SITE PAIN (arm was sore) and VACCINATION SITE SWELLING (arm was sore, swollen, very itchy, hard, and hot to the touch) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment medications were provided.

Other Meds:

Current Illness:

ID: 1581150
Sex: F
Age:
State: CA

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itchiness redness a rash in her arm near the injection site; Itchiness redness a rash in her arm near the injection site; Itchiness redness a rash in her arm near the injection site; Soreness on her arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness on her arm), VACCINATION SITE PRURITUS (Itchiness redness a rash in her arm near the injection site), VACCINATION SITE ERYTHEMA (Itchiness redness a rash in her arm near the injection site) and VACCINATION SITE RASH (Itchiness redness a rash in her arm near the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042l20a) for COVID-19 vaccination. No Medical History information was reported. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness on her arm). On 28-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness redness a rash in her arm near the injection site), VACCINATION SITE ERYTHEMA (Itchiness redness a rash in her arm near the injection site) and VACCINATION SITE RASH (Itchiness redness a rash in her arm near the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 22-Jan-2021, VACCINATION SITE PAIN (Soreness on her arm) had resolved. At the time of the report, VACCINATION SITE PRURITUS (Itchiness redness a rash in her arm near the injection site), VACCINATION SITE ERYTHEMA (Itchiness redness a rash in her arm near the injection site) and VACCINATION SITE RASH (Itchiness redness a rash in her arm near the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided.

Other Meds:

Current Illness:

ID: 1581151
Sex: F
Age: 38
State: NJ

Vax Date: 01/23/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: back pain; neck pain; temporary fever (24 hours); chills (48 hours); This spontaneous case was reported by a non-health professional and describes the occurrence of in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. No Medical History information was reported. On 23-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided.

Other Meds:

Current Illness:

ID: 1581152
Sex: F
Age:
State:

Vax Date: 01/16/2021
Onset Date: 01/25/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itching at the injection site; This spontaneous case was reported by a patient and describes the occurrence of in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for an unknown indication. No Medical History information was reported. On 16-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. No concomitant medications were provided. Treatment medications include Benadryl.. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1581153
Sex: M
Age: 55
State: NJ

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itchiness at the injection site; Rash under left arm pit area; Felt light headed; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Felt light headed), INJECTION SITE PRURITUS (Itchiness at the injection site) and RASH (Rash under left arm pit area) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032120A) for COVID-19 vaccination. No Medical History information was reported. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced DIZZINESS (Felt light headed). On an unknown date, the patient experienced INJECTION SITE PRURITUS (Itchiness at the injection site) and RASH (Rash under left arm pit area). At the time of the report, DIZZINESS (Felt light headed), INJECTION SITE PRURITUS (Itchiness at the injection site) and RASH (Rash under left arm pit area) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment medications were provided.

Other Meds:

Current Illness:

ID: 1581154
Sex: F
Age: 55
State: MN

Vax Date: 01/25/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of pyrexia (fever), headache and fatigue in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 029L20A) for COVID-19 immunization. No medical history reported. On Jan 25, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced pyrexia (fever), headache and fatigue. At the time of the report, pyrexia (fever), headache and fatigue outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Concomitant medication and treatment information not provided.

Other Meds:

Current Illness:

ID: 1581155
Sex: F
Age: 61
State: TX

Vax Date: 01/19/2021
Onset Date: 01/27/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: warm to touch; itching; red; sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm to touch), VACCINATION SITE PRURITUS (itching), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PAIN (sore) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. Concurrent medical conditions included Diabetes. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE WARMTH (warm to touch), VACCINATION SITE PRURITUS (itching), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PAIN (sore). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 27-Jan-2021 for Adverse event following immunisation, at an unspecified dose and frequency; HYDROCORTISONE on 27-Jan-2021 for Adverse event following immunisation, at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) on 27-Jan-2021 for Adverse event following immunisation, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (warm to touch), VACCINATION SITE PRURITUS (itching), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PAIN (sore) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported.

Other Meds:

Current Illness: Diabetes

ID: 1581156
Sex: F
Age:
State: CA

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Injection site itchy; Injection site a little swollen; 3 inch red area around the injection site; Soreness in her arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in her arm), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE SWELLING (Injection site a little swollen) and VACCINATION SITE ERYTHEMA (3 inch red area around the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Arrhythmia (NOS). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (Soreness in her arm). On 25-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE SWELLING (Injection site a little swollen) and VACCINATION SITE ERYTHEMA (3 inch red area around the injection site). At the time of the report, PAIN IN EXTREMITY (Soreness in her arm), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE SWELLING (Injection site a little swollen) and VACCINATION SITE ERYTHEMA (3 inch red area around the injection site) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Additional concomitant product used include blood thinner NOS and medicine for her arritmia (arrhythmia). Soreness in her arm lasted 3-4 days. No treatment medications were reported.

Other Meds: SYNTHROID

Current Illness: Arrhythmia (NOS)

ID: 1581157
Sex: F
Age: 42
State: OR

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: hot to the touch; initially had swelling on arm/ area where I received the vaccine is swollen again; Initially she had some swelling on her and redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot to the touch), VACCINATION SITE SWELLING (initially had swelling on arm/ area where I received the vaccine is swollen again) and VACCINATION SITE ERYTHEMA (Initially she had some swelling on her and redness) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. Concurrent medical conditions included Asthma. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]), HYDROCHLOROTHIAZIDE, METFORMIN, LOSARTAN, PROGESTERONE and LIOTHYRONINE. On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE SWELLING (initially had swelling on arm/ area where I received the vaccine is swollen again) and VACCINATION SITE ERYTHEMA (Initially she had some swelling on her and redness). On 26-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot to the touch). At the time of the report, VACCINATION SITE WARMTH (hot to the touch) outcome was unknown and VACCINATION SITE SWELLING (initially had swelling on arm/ area where I received the vaccine is swollen again) and VACCINATION SITE ERYTHEMA (Initially she had some swelling on her and redness) had resolved with sequelae. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided. Patient also states she is taking an inhaler and a birth control pill, however medication name was not specified. Patient also reported she received an allergy shot in the same arm on Thursday, 21JAN2021, but not in the same area as the vaccine.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]; HYDROCHLOROTHIAZIDE; METFORMIN; LOSARTAN; PROGESTERONE; LIOTHYRONINE

Current Illness: Asthma

ID: 1581158
Sex: F
Age: 67
State: FL

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm hurts a little bit more than usual; pain at the injection site; pain in shoulder; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (arm hurts a little bit more than usual), VACCINATION SITE PAIN (pain at the injection site) and ARTHRALGIA (pain in shoulder) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. Concurrent medical conditions included Pain (She has always had refractory pain on her left arm and shoulder. On the day of the vaccination the pain happened at the injection site.). Concomitant products included METFORMIN and LEVOTHYROXINE for an unknown indication. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE PAIN (pain at the injection site) and ARTHRALGIA (pain in shoulder). On 09-Jan-2021, the patient experienced PAIN (arm hurts a little bit more than usual). On 09-Jan-2021, VACCINATION SITE PAIN (pain at the injection site) and ARTHRALGIA (pain in shoulder) had resolved. At the time of the report, PAIN (arm hurts a little bit more than usual) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient also reported using Natural hormones concomitantly. No treatment medications were reported.

Other Meds: METFORMIN; LEVOTHYROXINE

Current Illness: Pain (She has always had refractory pain on her left arm and shoulder. On the day of the vaccination the pain happened at the injection site.)

ID: 1581159
Sex: F
Age: 53
State: CA

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Injection site was warm to touch; Arm was sore; Injection site Induration; Tired; Really high fever (101-102 F); Queasy; Injection site swelling; Chills; Headache; had some swelling on her arm and redness; Eyes were burning; Unbalanced; Experienced shortness of breath; This spontaneous case was reported by a nurse and describes the occurrence of EYE IRRITATION (Eyes were burning), BALANCE DISORDER (Unbalanced), DYSPNOEA (Experienced shortness of breath), VACCINATION SITE WARMTH (Injection site was warm to touch) and PAIN IN EXTREMITY (Arm was sore) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced EYE IRRITATION (Eyes were burning), BALANCE DISORDER (Unbalanced), DYSPNOEA (Experienced shortness of breath), PAIN IN EXTREMITY (Arm was sore), INJECTION SITE INDURATION (Injection site Induration), FATIGUE (Tired), PYREXIA (Really high fever (101-102 F)), NAUSEA (Queasy), INJECTION SITE SWELLING (Injection site swelling), CHILLS (Chills), HEADACHE (Headache) and VACCINATION SITE ERYTHEMA (had some swelling on her arm and redness). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Injection site was warm to touch). On 23-Jan-2021, PYREXIA (Really high fever (101-102 F)) was resolving. At the time of the report, EYE IRRITATION (Eyes were burning), BALANCE DISORDER (Unbalanced), DYSPNOEA (Experienced shortness of breath), VACCINATION SITE WARMTH (Injection site was warm to touch), PAIN IN EXTREMITY (Arm was sore), INJECTION SITE INDURATION (Injection site Induration), FATIGUE (Tired), NAUSEA (Queasy), INJECTION SITE SWELLING (Injection site swelling), CHILLS (Chills), HEADACHE (Headache) and VACCINATION SITE ERYTHEMA (had some swelling on her arm and redness) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jan-2021, Pyrexia: 101-102 (High) Degree F, had fever that lasted till 23Jan2021. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. Patient used acetaminophen and ice packs to treat symptoms.

Other Meds:

Current Illness:

ID: 1581160
Sex: F
Age:
State: FL

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: saw two big , red areas , like two big spots , and are warm to touch; saw two big , red areas , like two big spots , and are warm to touch; tenderness; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tenderness), ERYTHEMA (saw two big , red areas , like two big spots , and are warm to touch) and FEELING HOT (saw two big , red areas , like two big spots , and are warm to touch) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0131.20A) for COVID-19 vaccination. No Medical History information was reported. On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced TENDERNESS (tenderness). On 29-Jan-2021, the patient experienced ERYTHEMA (saw two big , red areas , like two big spots , and are warm to touch) and FEELING HOT (saw two big , red areas , like two big spots , and are warm to touch). At the time of the report, TENDERNESS (tenderness), ERYTHEMA (saw two big , red areas , like two big spots , and are warm to touch) and FEELING HOT (saw two big , red areas , like two big spots , and are warm to touch) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1581161
Sex: F
Age: 54
State: KY

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Positive for Covid-19; achiness; headache; blurred vision; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (blurred vision), COVID-19 (Positive for Covid-19), MYALGIA (achiness) and HEADACHE (headache) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030l20a) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VISION BLURRED (blurred vision), MYALGIA (achiness) and HEADACHE (headache). On 25-Jan-2021, the patient experienced COVID-19 (Positive for Covid-19). The patient was treated with PARACETAMOL (TYLENOL) 22-Jan-2021 for Adverse event following immunisation, at a dose of UNK dosage form. At the time of the report, VISION BLURRED (blurred vision), COVID-19 (Positive for Covid-19), MYALGIA (achiness) and HEADACHE (headache) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jan-2021, SARS-CoV-2 test: positive (Positive) tested positive for COVID-19. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1581162
Sex: M
Age: 90
State: ND

Vax Date: 01/13/2021
Onset Date: 01/20/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Little red spot on back, stomach; itching redspot; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Little red spot on back, stomach) and RASH PRURITIC (itching redspot) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included PRAVASTATIN, FINASTERIDE, LOSARTAN, SERTRALINE, TAMSULOSIN and VITAMINS NOS for an unknown indication. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced RASH MACULAR (Little red spot on back, stomach) and RASH PRURITIC (itching redspot). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 20-Jan-2021 for Adverse event following immunisation, at an unspecified dose and frequency. At the time of the report, RASH MACULAR (Little red spot on back, stomach) and RASH PRURITIC (itching redspot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: PRAVASTATIN; FINASTERIDE; LOSARTAN; SERTRALINE; TAMSULOSIN; VITAMINS NOS

Current Illness:

ID: 1581163
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: local reaction at injection site; local reaction at injection site. It was a large, indurated area of redness; local reaction at injection site. It was a large, indurated area of redness; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE REACTION (local reaction at injection site ), VACCINATION SITE INDURATION (local reaction at injection site. It was a large, indurated area of redness) and VACCINATION SITE ERYTHEMA (local reaction at injection site. It was a large, indurated area of redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (local reaction at injection site ), VACCINATION SITE INDURATION (local reaction at injection site. It was a large, indurated area of redness) and VACCINATION SITE ERYTHEMA (local reaction at injection site. It was a large, indurated area of redness). At the time of the report, VACCINATION SITE REACTION (local reaction at injection site ), VACCINATION SITE INDURATION (local reaction at injection site. It was a large, indurated area of redness) and VACCINATION SITE ERYTHEMA (local reaction at injection site. It was a large, indurated area of redness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1581164
Sex: F
Age: 45
State: AZ

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hives on hand,on legs,on torso,on buttocks; itchiness; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives on hand,on legs,on torso,on buttocks) and PRURITUS (itchiness) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010m20a) for COVID-19 vaccination. No Medical History information was reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced URTICARIA (Hives on hand,on legs,on torso,on buttocks) and PRURITUS (itchiness). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing from 28-Jan-2021 for Hives, at a dose of 2 Tab as required. At the time of the report, URTICARIA (Hives on hand,on legs,on torso,on buttocks) and PRURITUS (itchiness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1581165
Sex: M
Age: 58
State: TN

Vax Date: 01/27/2021
Onset Date: 01/28/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: headache; chills; got warm and thinks he has small fever; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), CHILLS (chills) and PYREXIA (got warm and thinks he has small fever) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030l20a) for COVID-19 vaccination. Concurrent medical conditions included Blood pressure abnormal. Concomitant products included CLONIDINE and AMLODIPINE for Blood pressure management, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and ALPRAZOLAM for an unknown indication. On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced HEADACHE (headache), CHILLS (chills) and PYREXIA (got warm and thinks he has small fever). At the time of the report, HEADACHE (headache), CHILLS (chills) and PYREXIA (got warm and thinks he has small fever) outcome was unknown. For treatment patient reported in middle of the night took migraine medicine, and today flu medicine (unspecified)

Other Meds: CLONIDINE; ASPIRIN (E.C.); AMLODIPINE; ALPRAZOLAM

Current Illness: Blood pressure abnormal

ID: 1581166
Sex: F
Age: 41
State: UT

Vax Date: 01/28/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Elevated Heart Rate; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Elevated Heart Rate) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (Elevated Heart Rate). At the time of the report, HEART RATE INCREASED (Elevated Heart Rate) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1581167
Sex: F
Age: 32
State: IL

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: getting brown; felt like a hot sunburn almost like a hand size; itchy; started getting hot, red bumps on left arm where she got vaccine; pain, like sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain, like sore), RASH ERYTHEMATOUS (started getting hot, red bumps on left arm where she got vaccine), SUNBURN (felt like a hot sunburn almost like a hand size), TANNING (getting brown) and VACCINATION SITE PRURITUS (itchy) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced PAIN (pain, like sore). On 24-Jan-2021, the patient experienced RASH ERYTHEMATOUS (started getting hot, red bumps on left arm where she got vaccine) and VACCINATION SITE PRURITUS (itchy). On 25-Jan-2021, the patient experienced SUNBURN (felt like a hot sunburn almost like a hand size). On 27-Jan-2021, the patient experienced TANNING (getting brown). At the time of the report, PAIN (pain, like sore), RASH ERYTHEMATOUS (started getting hot, red bumps on left arm where she got vaccine), SUNBURN (felt like a hot sunburn almost like a hand size), TANNING (getting brown) and VACCINATION SITE PRURITUS (itchy) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1581168
Sex: U
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: develops a numbness and tingling of the mouth and tongue immediately following the first dose; develops a numbness and tingling of the mouth and tongue immediately following the first dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of HYPOAESTHESIA ORAL (develops a numbness and tingling of the mouth and tongue immediately following the first dose) and PARAESTHESIA ORAL (develops a numbness and tingling of the mouth and tongue immediately following the first dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Angioedema. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA ORAL (develops a numbness and tingling of the mouth and tongue immediately following the first dose) and PARAESTHESIA ORAL (develops a numbness and tingling of the mouth and tongue immediately following the first dose). At the time of the report, HYPOAESTHESIA ORAL (develops a numbness and tingling of the mouth and tongue immediately following the first dose) and PARAESTHESIA ORAL (develops a numbness and tingling of the mouth and tongue immediately following the first dose) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. no treatment medications were reported. Per physician reporting the event, patient had history of angioedema with other medications, and developed reactions of numbness and tingling of mouth immediately following first dose. This case was linked to MOD-2021-023363, MOD-2021-019227 (Patient Link).

Other Meds:

Current Illness:

ID: 1581169
Sex: F
Age: 30
State: NY

Vax Date: 01/08/2021
Onset Date: 01/24/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: The back of her head is in a lot of pain; The neck is in a lot of pain; A spontaneous report was received from a consumer concerning a 30-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events back of her head is in a lot of pain, the neck is in a lot of pain. The patient's medical history was not provided. No relevant concomitant medications were reported. On 8 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) in the left arm for prophylaxis of COVID-19 infection. On 24 Jan 2021, the patient experienced the event back of her head is in a lot of pain, the neck is in a lot of pain. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of event(s), back of her head is in a lot of pain was unknown.The outcome of event(s), the neck is in a lot of pain was unknown..; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1581170
Sex: F
Age: 69
State: CA

Vax Date: 01/27/2021
Onset Date: 01/28/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swelling at facial filler injection site; Itching at facial filler injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of SWELLING FACE (Swelling at facial filler injection site) and PRURITUS (Itching at facial filler injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. Patients previous medical history included administration of Juvederm facial fillers in lips and cheek. On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced SWELLING FACE (Swelling at facial filler injection site) and PRURITUS (Itching at facial filler injection site). At the time of the report, SWELLING FACE (Swelling at facial filler injection site) and PRURITUS (Itching at facial filler injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment medications were reported.

Other Meds:

Current Illness:

ID: 1581171
Sex: F
Age: 47
State: NY

Vax Date: 01/08/2021
Onset Date: 01/01/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tingling on and off; fatigue; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (tingling on and off) and FATIGUE (fatigue) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. Concurrent medical conditions included Migraine (Bad history of migraine). On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced PARAESTHESIA (tingling on and off) and FATIGUE (fatigue). At the time of the report, PARAESTHESIA (tingling on and off) and FATIGUE (fatigue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. Her physician reported , she was given epitome to prevent anaphylactic reaction.

Other Meds:

Current Illness: Migraine (Bad history of migraine)

ID: 1581172
Sex: F
Age: 67
State: FL

Vax Date: 12/29/2020
Onset Date: 01/28/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm Pain; Chills; Fever; Headache; Nausea; Body Aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm Pain), CHILLS (Chills), PYREXIA (Fever), HEADACHE (Headache) and NAUSEA (Nausea) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm Pain), CHILLS (Chills), PYREXIA (Fever), HEADACHE (Headache), NAUSEA (Nausea) and MYALGIA (Body Aches). At the time of the report, PAIN IN EXTREMITY (Arm Pain), CHILLS (Chills), PYREXIA (Fever), HEADACHE (Headache), NAUSEA (Nausea) and MYALGIA (Body Aches) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1581173
Sex: F
Age: 64
State: TX

Vax Date: 01/19/2021
Onset Date: 01/19/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; fever; Muscle pain; joint pain; chills; nausea; swollen injection site; whole arm hurt; cough; Pain when she touched injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (whole arm hurt), COUGH (cough), VACCINATION SITE PAIN (Pain when she touched injection site pain), HEADACHE (Headache) and PYREXIA (fever) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. Concomitant products included EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE (SYNJARDY), LISINOPRIL, ATORVASTATIN and OMEPRAZOLE for an unknown indication. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain when she touched injection site pain). On 27-Jan-2021, the patient experienced PAIN IN EXTREMITY (whole arm hurt), COUGH (cough), HEADACHE (Headache), PYREXIA (fever), MYALGIA (Muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (nausea) and VACCINATION SITE SWELLING (swollen injection site). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (whole arm hurt), COUGH (cough), VACCINATION SITE PAIN (Pain when she touched injection site pain), HEADACHE (Headache), PYREXIA (fever), MYALGIA (Muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), NAUSEA (nausea) and VACCINATION SITE SWELLING (swollen injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: SYNJARDY; LISINOPRIL; ATORVASTATIN; OMEPRAZOLE

Current Illness:

ID: 1581174
Sex: M
Age:
State: TX

Vax Date:
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itch at injection site; Rash and itch at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itch at injection site) and VACCINATION SITE RASH (Rash and itch at injection site) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057K20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itch at injection site) and VACCINATION SITE RASH (Rash and itch at injection site). At the time of the report, VACCINATION SITE PRURITUS (itch at injection site) and VACCINATION SITE RASH (Rash and itch at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1581175
Sex: M
Age:
State: OH

Vax Date:
Onset Date: 01/29/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: chills; headache; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), HEADACHE (headache) and PAIN IN EXTREMITY (sore arm) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. Concomitant products included LISINOPRIL and ROSUVASTATIN for an unknown indication. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced CHILLS (chills), HEADACHE (headache) and PAIN IN EXTREMITY (sore arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, CHILLS (chills), HEADACHE (headache) and PAIN IN EXTREMITY (sore arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: LISINOPRIL; ROSUVASTATIN

Current Illness:

ID: 1581176
Sex: F
Age:
State: NC

Vax Date: 01/14/2021
Onset Date: 01/28/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: injection site hardness; injection site redness; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (injection site hardness), PAIN IN EXTREMITY (Sore arm) and VACCINATION SITE ERYTHEMA (injection site redness) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination. No Medical History information was reported. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On an unknown date, the patient experienced VACCINATION SITE REACTION (injection site hardness) and VACCINATION SITE ERYTHEMA (injection site redness). At the time of the report, VACCINATION SITE REACTION (injection site hardness), PAIN IN EXTREMITY (Sore arm) and VACCINATION SITE ERYTHEMA (injection site redness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1581177
Sex: F
Age:
State: CO

Vax Date: 01/16/2021
Onset Date: 01/28/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Red circle around the injection site and warm to the touch; A red circle around the injection site; A spontaneous report was received from a Consumer concerning a female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events a red circle around the injection site, warm to the touch. The patient's medical history was not provided. No relevant concomitant medications were reported. On 16 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (Batch Number: Unknown) intramuscularly for prophylaxis of COVID-19 infection. On 28 Jan 2021, the patient experienced the events of a red circle around the injection site and warm to the touch. No treatment information was provided Action taken with mRNA-1273 in response to the events was not reported. The outcome of events, a red circle around the injection site and warm to the touch was not reported..; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.

Other Meds:

Current Illness:

ID: 1581178
Sex: M
Age:
State: SC

Vax Date:
Onset Date: 01/25/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm sores; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (Arm sores) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm sores). The patient was treated with ALCOHOL (topical) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (Arm sores) was resolving. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Outcome added as recovering. Consumer doesn't need further follow-up.

Other Meds:

Current Illness:

ID: 1581179
Sex: F
Age:
State: PA

Vax Date:
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain in left arm for 36 hours; Diarrhea twice a morning every day; Tenderness at back of neck/base of neck/clavicle; Swollen lymph nodes on left side; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (Pain in left arm for 36 hours), DIARRHOEA (Diarrhea twice a morning every day), TENDERNESS (Tenderness at back of neck/base of neck/clavicle) and LYMPHADENOPATHY (Swollen lymph nodes on left side) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Mucocutaneous lymph node syndrome (at the age of 4 years). On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Pain in left arm for 36 hours), DIARRHOEA (Diarrhea twice a morning every day), TENDERNESS (Tenderness at back of neck/base of neck/clavicle) and LYMPHADENOPATHY (Swollen lymph nodes on left side). The patient was treated with LOPERAMIDE HYDROCHLORIDE (IMODIUM) at an unspecified dose and frequency. On 15-Jan-2021, PAIN (Pain in left arm for 36 hours), TENDERNESS (Tenderness at back of neck/base of neck/clavicle) and LYMPHADENOPATHY (Swollen lymph nodes on left side) had resolved. On 22-Jan-2021, DIARRHOEA (Diarrhea twice a morning every day) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. patient uses unspecified allergic concomitant medications.

Other Meds:

Current Illness:

ID: 1581180
Sex: F
Age: 48
State:

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: sneezed; lost her voice; cough; post nasal drainage; sinus headache; itchiness at the injection site; arm soreness; chills; really tired; achy all over; pain all over; This spontaneous case was reported by a physician and describes the occurrence of INJECTION SITE PRURITUS (itchiness at the injection site), ARTHRALGIA (arm soreness), CHILLS (chills), FATIGUE (really tired) and PAIN (achy all over) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced INJECTION SITE PRURITUS (itchiness at the injection site), ARTHRALGIA (arm soreness), CHILLS (chills), FATIGUE (really tired), PAIN (achy all over) and PAIN (pain all over). On 27-Jan-2021, the patient experienced COUGH (cough), RHINORRHOEA (post nasal drainage) and SINUS HEADACHE (sinus headache). On 28-Jan-2021, the patient experienced APHONIA (lost her voice). On an unknown date, the patient experienced SNEEZING (sneezed). At the time of the report, INJECTION SITE PRURITUS (itchiness at the injection site), ARTHRALGIA (arm soreness), CHILLS (chills), FATIGUE (really tired), PAIN (achy all over), PAIN (pain all over), COUGH (cough), RHINORRHOEA (post nasal drainage), SINUS HEADACHE (sinus headache), APHONIA (lost her voice) and SNEEZING (sneezed) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant information provided. Treatment included Aleve Most recent FOLLOW-UP information incorporated above includes: On 27-Jan-2021: No new information reported.

Other Meds:

Current Illness:

ID: 1581181
Sex: F
Age:
State: KY

Vax Date:
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain in axillary area; Pain at injection site; redness at injection site; This spontaneous case was reported by an other and describes the occurrence of AXILLARY PAIN (Pain in axillary area), VACCINATION SITE PAIN (Pain at injection site) and VACCINATION SITE ERYTHEMA (redness at injection site) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced AXILLARY PAIN (Pain in axillary area), VACCINATION SITE PAIN (Pain at injection site) and VACCINATION SITE ERYTHEMA (redness at injection site). At the time of the report, AXILLARY PAIN (Pain in axillary area), VACCINATION SITE PAIN (Pain at injection site) and VACCINATION SITE ERYTHEMA (redness at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1581182
Sex: M
Age:
State: FL

Vax Date:
Onset Date: 01/05/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pain in arm; stiffness of shoulder/neck; tenderness; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tenderness), PAIN IN EXTREMITY (pain in arm) and MUSCULOSKELETAL STIFFNESS (stiffness of shoulder/neck) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. No Medical History information was reported. On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced TENDERNESS (tenderness). On 29-Jan-2021, the patient experienced PAIN IN EXTREMITY (pain in arm) and MUSCULOSKELETAL STIFFNESS (stiffness of shoulder/neck). At the time of the report, TENDERNESS (tenderness), PAIN IN EXTREMITY (pain in arm) and MUSCULOSKELETAL STIFFNESS (stiffness of shoulder/neck) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1581183
Sex: F
Age:
State: PA

Vax Date:
Onset Date: 01/22/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: swollen gland on neck under jaw on the right side of their neck; swollen gland under the jaw; sore arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm), SWELLING (swollen gland on neck under jaw on the right side of their neck) and LYMPHADENOPATHY (swollen gland under the jaw) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included Breast cosmetic surgery and Dental implant user since an unknown date. Concomitant products included PARACETAMOL (TYLENOL A) and LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for an unknown indication. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 27-Jan-2021, the patient experienced SWELLING (swollen gland on neck under jaw on the right side of their neck) and LYMPHADENOPATHY (swollen gland under the jaw). On 24-Jan-2021, PAIN IN EXTREMITY (sore arm) had resolved. At the time of the report, SWELLING (swollen gland on neck under jaw on the right side of their neck) and LYMPHADENOPATHY (swollen gland under the jaw) outcome was unknown. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, X-ray: normal normal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: TYLENOL A; BENADRYL 24 D

Current Illness: Dental implant user

ID: 1581184
Sex: F
Age: 63
State: FL

Vax Date: 01/20/2021
Onset Date: 01/22/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: flu-like symptoms; A spontaneous report was received from a Consumer concerning a 64-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events flu-like symptoms. The patient's medical history was not provided. No relevant concomitant medications were reported. On 20 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot batch: 032L20A) intramuscularly for prophylaxis of COVID-19 infection. On 22 Jan 2021, the patient experienced the events flu-like symptoms. Treatment details included Advil Action taken with mRNA-1273 in response to the events was not reported. On an unknown date the outcome of events include, flu-like symptoms was not reported.

Other Meds:

Current Illness:

ID: 1581185
Sex: F
Age:
State: OH

Vax Date: 01/30/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: cough; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough) and FATIGUE (tiredness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COUGH (cough) and FATIGUE (tiredness). The patient was treated with OXYMETAZOLINE HYDROCHLORIDE (CORICIDIN [OXYMETAZOLINE HYDROCHLORIDE]) at a dose of 1 dosage form and AZITHROMYCIN (Z-PAK) at a dose of 1 dosage form. At the time of the report, COUGH (cough) and FATIGUE (tiredness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not reported.

Other Meds:

Current Illness:

ID: 1581186
Sex: U
Age:
State:

Vax Date:
Onset Date: 01/24/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rash at the injection site; Itching at the injection site; headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash at the injection site), VACCINATION SITE PRURITUS (Itching at the injection site) and HEADACHE (headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNKNOWN) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash at the injection site), VACCINATION SITE PRURITUS (Itching at the injection site) and HEADACHE (headache). At the time of the report, VACCINATION SITE RASH (Rash at the injection site), VACCINATION SITE PRURITUS (Itching at the injection site) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1581187
Sex: F
Age: 26
State: KY

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: injection arm itchiness; injection arm redness; injection arm bruising; chills; fatigue; headache; body aches; injection arm sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (injection arm sore), FATIGUE (fatigue), HEADACHE (headache), PAIN (body aches) and CHILLS (chills) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History was provided by the reporter. Concomitant products included FLUOXETINE and ETHINYLESTRADIOL, NORELGESTROMIN (XULANE) for an unknown indication. On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE PAIN (injection arm sore). On 21-Jan-2021, the patient experienced FATIGUE (fatigue), HEADACHE (headache) and PAIN (body aches). On 27-Jan-2021, the patient experienced CHILLS (chills). On 28-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection arm redness) and VACCINATION SITE BRUISING (injection arm bruising). On 29-Jan-2021, the patient experienced INJECTION SITE PRURITUS (injection arm itchiness). The patient was treated with ACETAMINOPHEN for Adverse event, at an unspecified dose and frequency. On 25-Jan-2021, FATIGUE (fatigue), HEADACHE (headache) and PAIN (body aches) had resolved. On 26-Jan-2021, VACCINATION SITE PAIN (injection arm sore) had resolved. On 27-Jan-2021, CHILLS (chills) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (injection arm redness), VACCINATION SITE BRUISING (injection arm bruising) and INJECTION SITE PRURITUS (injection arm itchiness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: FLUOXETINE; XULANE

Current Illness:

ID: 1581188
Sex: F
Age: 70
State: PA

Vax Date: 01/28/2021
Onset Date:
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Very sore left deltoid at injection site; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (Very sore left deltoid at injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L2(or Z)0A) for COVID-19 vaccination. No Medical History was provided by the reporter. Concurrent medical conditions included Sulfonamide allergy. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Very sore left deltoid at injection site). At the time of the report, VACCINATION SITE PAIN (Very sore left deltoid at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness: Sulfonamide allergy

ID: 1581189
Sex: M
Age: 66
State: PR

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: numbness in the lower lip; felt like having ants (like "hormigas"); the lip stayed down, couldn't lift it; This spontaneous case was reported by a patient and describes the occurrence of in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. No Medical History information was reported. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. On 25-Jan-2021 the patient experienced numbness in their lower lip 30 min to an hour after the shot. felt like having ants (like hormigas), the lip stayed down, couldn't lift it. It was just a little bit, now is 90% already in its place. Treatment of the event was not reported. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1581190
Sex: M
Age:
State: NY

Vax Date: 01/11/2021
Onset Date: 01/11/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: My arm hurt a little bit.; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (My arm hurt a little bit.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNKNOWN) for COVID-19 vaccination. No medical history was provided by the reporter. On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced PAIN IN EXTREMITY (My arm hurt a little bit.). At the time of the report, PAIN IN EXTREMITY (My arm hurt a little bit.) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications were not provided. Treatment details were not provided; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1581191
Sex: F
Age: 73
State: CO

Vax Date: 01/18/2021
Onset Date: 01/25/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: flu-like symptoms; chills; arm started swelling up; real red; very sore; had a lot of itch; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE SWELLING (arm started swelling up), VACCINATION SITE ERYTHEMA (real red), VACCINATION SITE PAIN (very sore), VACCINATION SITE PRURITUS (had a lot of itch) and INFLUENZA LIKE ILLNESS (flu-like symptoms) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029120A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by reporter. Concomitant products included CETIRIZINE for Allergy, LISINOPRIL, ROSUVASTATIN CALCIUM (CRESTOR) and POTASSIUM for an unknown indication. On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE SWELLING (arm started swelling up), VACCINATION SITE ERYTHEMA (real red), VACCINATION SITE PAIN (very sore) and VACCINATION SITE PRURITUS (had a lot of itch). On 26-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms) and CHILLS (chills). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at a dose of 325 milligram. At the time of the report, VACCINATION SITE SWELLING (arm started swelling up), VACCINATION SITE ERYTHEMA (real red), VACCINATION SITE PAIN (very sore), VACCINATION SITE PRURITUS (had a lot of itch), INFLUENZA LIKE ILLNESS (flu-like symptoms) and CHILLS (chills) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Reporter did not allow further contact

Other Meds: LISINOPRIL; CRESTOR; POTASSIUM; CETIRIZINE

Current Illness:

ID: 1581192
Sex: F
Age: 84
State: OH

Vax Date: 01/22/2021
Onset Date: 01/22/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pain around the injection site/soreness around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain around the injection site/soreness around the injection site) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), FISH OIL and ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D) for an unknown indication. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE PAIN (pain around the injection site/soreness around the injection site). At the time of the report, VACCINATION SITE PAIN (pain around the injection site/soreness around the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No Treatment information provided; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds: BABY ASPIRIN; FISH OIL

Current Illness:

ID: 1581193
Sex: F
Age: 68
State: DE

Vax Date: 01/22/2021
Onset Date: 01/13/2021
Rec V Date: 08/18/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: substantial exposure to Covid-19; field of vision was not normal; eyes were swelling and lowered; eye leads were swollen; arm a little sore; fatigue; potential allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm a little sore), EXPOSURE TO SARS-COV-2 (substantial exposure to Covid-19), ALLERGY TO VACCINE (potential allergic reaction), FATIGUE (fatigue) and VISUAL IMPAIRMENT (field of vision was not normal) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0381C20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Previously administered products included for Seasonal allergy: ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE] since an unknown date. Concurrent medical conditions included Dust allergy, Allergy to molds, Allergy to animals (Cats), Pollen allergy, Grass allergy (Allergic to trees), Allergy to chemicals (Patient is allergic to Codeine, Ziprol and Lagil) and Osteopenia (Patient has Osteopenia and receive a shot for this every 6 month). Concomitant products included GLUCOSAMINE for Joint pain, LEVOTHYROXINE, TRANEXAMIC ACID (NEXIM), MULTIVITAMIN [ASCORBIC ACID;BIOTIN;CALCIUM PANTOTHENATE;CYANOCOBALAMIN;FOLIC ACID;NICOTINIC ACID;PYRIDOXINE HYDROCHLORIDE;RIBOFLAVIN;THIAMINE HYDROCHLORIDE;TOCOPHERYL ACETATE], VITAMIN E NOS and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication. On 22-Jan-2021 at 4:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced ALLERGY TO VACCINE (potential allergic reaction). On 22-Jan-2021, the patient experienced VACCINATION SITE PAIN (arm a little sore) and FATIGUE (fatigue). On 23-Jan-2021, the patient experienced VISUAL IMPAIRMENT (field of vision was not normal), EYE SWELLING (eyes were swelling and lowered) and SWELLING OF EYELID (eye leads were swollen). On an unknown date, the patient experienced EXPOSURE TO SARS-COV-2 (substantial exposure to Covid-19). The patient was treated with PREDNISONE for Allergy, at a dose of 15 milligram and CHLORPHENAMINE MALEATE (ANTIHISTAMINICO) on 23-Jan-2021 for Swollen eyes, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (arm a little sore) outcome was unknown, EXPOSURE TO SARS-COV-2 (substantial exposure to Covid-19) had resolved and ALLERGY TO VACCINE (potential allergic reaction), FATIGUE (fatigue), VISUAL IMPAIRMENT (field of vision was not normal), EYE SWELLING (eyes were swelling and lowered) and SWELLING OF EYELID (eye leads were swollen) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test negative: negative (Negative) Patient was tested negative when she was taking care of her grandchild's who tested positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Patient treated swelling with Eye compress.

Other Meds: LEVOTHYROXINE; NEXIM; MULTIVITAMIN [ASCORBIC ACID;BIOTIN;CALCIUM PANTOTHENATE;CYANOCOBALAMIN;FOLIC ACID;NICOTINIC ACID;PYR; VITAMIN E NOS; VITAMIN D 2000; GLUCOSAMINE

Current Illness: Allergy to animals (Cats); Allergy to chemicals (Patient is allergic to Codeine, Ziprol and Lagil); Allergy to molds; Dust allergy; Grass allergy (Allergic to trees); Osteopenia (Patient has Osteopenia and receive a shot for this every 6 month); Pollen allergy

Total 2021 VAERS Injuries: 704,237

Page last modified: 03 October 2021 5:28pm